With a $112,250 grant from FRAXA Research Foundation over 3 years, Dr. Efthimios Skoulakis and his team from the Institute of Cellular and Developmental Biology conducted the first FRAXA project in Greece, where they developed a speedy new test for learning problems in fruit flies, which allowed them to test a number of drugs that are potential Fragile X treatments.
Read moreKanellpoulos, Alexandros
Alexandros Kanellpoulos, PhD, Senior Researcher at the University of Lausanne, studies how alterations in synaptic genes affect neurodegenerative disorders such as autism, schizophrenia, and various intellectual disabilities.